article thumbnail

Do generics producers have what it takes to tackle complex and specialty drugs?

Pharmaceutical Technology

For example, JAK inhibitors are oral drugs that feature a certain complexity, says Jonathan Watanabe, PhD, professor of Clinical Pharmacy at the University of California, Irvine. You need good production, good science and engineering, and you need good lawyers. The only way forward for generics producers. But there are some exceptions.

Drugs 298
article thumbnail

Cybersecurity in pharma: Securing the future

Pharmaceutical Technology

Social engineering attacks will rise, in addition to phishing, smishing and deepfake attacks. Pharmacies have also received EU General Data Protection Regulation (GDPR) fines for not being in compliance,” he adds. Pharmaceutical companies that are publicly traded will need to pay attention,” warns Kim.

Genome 276
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

What is a “legitimate” drug or online pharmacy?

Pharmacy Checkers

However, use of the word “legitimate” is found in the DSCSA, and that word is often misused by opponents of drug importation and international online pharmacies – and that got me thinking. On the subjects of drug importation, online pharmacy verification, drug safety and affordability, the word “legitimate” is thrown around a lot.

article thumbnail

Leading patient adherence pharmaceutical companies

Pharmaceutical Technology

The AI engine predicts and identifies patients who are at risk and optimises interventions for them by channel, messages and timing. They also partner with retail pharmacy chains, pharmacy network aggregators, and consumer behaviour data companies on behalf of pharmaceutical manufacturers to collect data for sourcing patient information.

Pharmacy 130
article thumbnail

Leading pharmaceutical logistics and pharma supply chain companies

Pharmaceutical Technology

The pharmaceutical supply chain is a global and complex network that includes a wide range of stakeholders such as pharmaceutical manufacturers, wholesale distributors, and pharmacy benefit managers (PBM), to ensure efficient and timely delivery of medications to the patients.

article thumbnail

STAT+: Pharmalittle: FDA approves a gene therapy for a rare blood disorder; pharmacy chains ordered to pay $650 million over opioid crisis

STAT News

It uses an engineered virus to deliver a gene fix into the bone marrow of patients. The therapy, Zynteglo, is just the third gene therapy approved by the FDA, and the first to target a chronic blood disease. Zynteglo will cost $2.8 million per patient, making it one of the most expensive medicines ever sold in the U.S.

article thumbnail

LegitScript Finds 1200 Percent Increase in Problematic Ads for Compounded GLP-1 Meds

XTalks

Compounded GLP-1 medications, created by specialized pharmacies under a special US Food and Drug Administration (FDA) allowance due to ongoing shortage, have become increasingly popular for weight loss. The report also shows a rapid rise in compounding pharmacies.

Pharmacy 104